Ratings by H.C. Wainwright (Jason Kolbert)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/5/2026 | Coherus Biosciences | CHRS | Maintain | Buy (Buy) |
|
Details | ||
| 4/29/2025 | Coherus Biosciences | CHRS | Maintain | Buy (Buy) |
|
Details | ||
| 3/11/2025 | Coherus Biosciences | CHRS | Upgrade | Buy (Buy) |
1.04 (1.82) |
75% | Details | |
| 12/4/2024 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2020 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2019 | Coherus Biosciences | CHRS | New Coverage | Buy (N/A) |
16.38 (1.04) |
-93.65% | Details | |
| 10/30/2018 | ADMA Biologics | ADMA | New Coverage | Buy (N/A) |
5.33 (2.89) |
-45.78% | Details | |
| 8/28/2018 | Coherus Biosciences | CHRS | New Coverage | Buy (N/A) |
18.90 (16.38) |
-13.33% | Details | |
| 8/20/2018 | IsoRay, Inc. | ISR | New Coverage | Neutral (N/A) |
0.57 (0.39) |
-31.58% | Details | |
| 8/15/2018 | Cytori Therapeutics, Inc. | CYTX | Maintain | Buy (N/A) |
|
Details |
